We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Field Test Allows Rapid Diagnosis of Chikungunya Virus Infection

By LabMedica International staff writers
Posted on 12 Oct 2016
Chikungunya virus (CHIKV) infection causes symptoms that are similar to Dengue and Zika as well as other viral diseases, including influenza and accurate diagnosis of CHIKV is important for effective outbreak responses, including patient management and mosquito control.

A reverse transcriptase (RT) recombinase polymerase amplification (RPA) assay has been developed for rapid detection of CHIKV in clinical samples. More...
RPA-based detection of small amounts of DNA is an alternative to polymerase chain reaction (PCR) and based on reactions that can run at constant temperatures.

An international team of scientists led by those at the Robert-Koch-Institute (Berlin, Germany) included in their study 78 patients with a history of sudden onset of fever, headache, fatigue, nausea, vomiting, rash, myalgia and severe and very painful polyarthralgia suggestive of CHIK infection. Fifty-eight plasma samples were provided by a group in Thailand and 20 CHIKV positive sera samples collected from patients suspected to be infected by CHIKV during routine medical examination, were provided by French scientists.

The team designed a set of CHIKV-specific reagents and showed that the assay was able to detect very small amounts of CHIKV ribonucleic acid (RNA). The RT-RPA assay was slightly less sensitive than RT-PCR, but both assays yielded identical results on clinical samples of 20 patients with known CHIKV infection and 58 samples from suspected cases.

Testing the RT-RPA assay on different CHIKV strains and a panel of related alpha - and arboviruses, the scientists found, that the assay reliably detected all 18 different CHIKV strains tested. In addition, there was no cross-reactivity of the assay with any of the other tested viruses except for the very closely related O'nyong'nyong virus (ONNV). Using a modified set of assay reagents, the scientists were able to eliminate the problem of false-positive results caused by ONNV. The diagnostic sensitivity and specificity of the CHIKV RT-RPA assay were determined at 100%.

The investigators highlighted that RPA reagents are stable at ambient temperature (25-38 °C), meaning they do not need to be refrigerated. The authors concluded that the CHIKV RPA assay is a promising tool for CHIKV diagnostics at the point of need. Integration into a multimer or multiplex assay for simultaneous and detection of CHIKV, Dengue virus and Zika virus as well as an internal control would improve outbreak investigations, since the three viruses induce same clinical picture upon infection and increasingly co-circulate in many parts of world. The study was published on September 29, 2016, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:
Robert-Koch-Institute


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Drug Testing Assays
Atellica DT 250 Analyzer
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Molecular Diagnostics

view channel
Image: Graphical Abstract (Image Credit: Cheng N, Ouellette TW, Skead K, et al. Pre-diagnosis plasma cell-free DNA reveals early signatures of prostate and breast cancer risk up to eight years prior to clinical detection. Cell Genomics (2026). DOI:10.1016/j.xgen.2026.101364)

Blood Test Stratifies Prostate and Breast Cancer Risk Years Before Diagnosis

Cancer is the second leading cause of death globally, and late diagnosis contributes substantially to mortality. Routine screening is available for only a few cancer types, while other early detection... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Collaboration combines cognitive assessment, blood testing, phlebotomy, and MRI to support faster diagnosis across the UK (Image Credt: Adobe Stock)

New UK Collaboration Expands Access to Integrated Alzheimer’s Diagnostic Testing

C2N Diagnostics and Cambridge Cognition have partnered with The Alzheimer’s Trust to create an integrated pathway aimed at supporting earlier and more accurate diagnosis of Alzheimer’s disease and related dementias.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.